Skip to content

Clinical trials

Schizophrenia trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Country / region: Italy Clear all

65 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20033
20042
20051
20062
20071
20084
20091
20104
20114
20123
20133
20141
20151
20162
20178
20183
20193
20202
20213
20226
20231
20244
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48
Unknown status8
Terminated3
Active, not recruiting2
Not yet recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Hoffmann-La Roche4
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4
Boehringer Ingelheim3
Otsuka Pharmaceutical Development & Commercialization, Inc.3
ACADIA Pharmaceuticals Inc.2
Alkermes, Inc.2
Aziende Chimiche Riunite Angelini Francesco S.p.A2
FORUM Pharmaceuticals Inc2
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia65
Psychotic Disorders9
Cognition Disorders3
Mental Disorders3
Metabolic Syndrome3
Obsessive-Compulsive Disorder2
Antisocial Personality Disorder1
Anxiety Disorders1
Bipolar Disorder1
Brain Injuries, Traumatic1

Trials

Showing 76 to 65 of 65. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.